In prostate cancer metastases, the density of FSHR-positive blood vessels in metastases was about 3 times higher than in the tumor interior, suggesting that FSHR may be significantly associated with, and potentially actively contributes to, prostate cancer metastasis (Sakai et al., 2015). This evidence concerns the gene FSHR and prostate cancer.